引用本文:徐新华,张国刚,王 林,杨勤玲,张毓萍.金属类抗癌药物的研究进展[J].大连医科大学学报,2012,34(5):511-514.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 次   下载 本文二维码信息
码上扫一扫!
分享到: 微信 更多
金属类抗癌药物的研究进展
徐新华,张国刚,王 林,杨勤玲,张毓萍
西安交通大学 第一附属医院 肝胆外科,西安 710061
摘要:
在新型抗癌药物中,金属类抗癌药物已成为重要的一类。金属类抗癌药物有许多其它药物无法比拟的独特性质,近年,新的高效、低毒、具有抗癌活性的金属化合物不断被合成出来。其中有铂类抗癌药物,有机锡及其配合物、有机锗化合物、钯配合物、钌配合物、铜配位化合物、钛类化合物等,本文综述了这些化合物在抗癌领域的研究与应用新进展。
关键词:  抗癌药物  抗癌活性  金属配合物
DOI:10.11724/jdmu.2012.05.23
分类号:
基金项目:
Metal-based anticancer drug research progress
XU Xin-hua, ZHANG Guo-gang, WANG Lin, YANG Qin-ling, ZHANG Yu-ping
Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xi’ an JiaoTong University, Xi’ an 710061,China
Abstract:
In recent years, metal-based anti-cancer drugs have become one important type among the new developing anti-cancer drugs. Metal-based anti-cancer drugs have many unique properties that are superior to those of other drugs. With the further understanding of the pharmacological action of the metal complexes, the new metal compounds with high efficiency, low toxicity, and anticancer activity were continuously synthesized. Those compounds included platinum anti-cancer drugs, organic tin complexes, organic germanium compound, palladium complexes, ruthenium complexes, copper coordination compounds, titanium compounds, etc. This article reviews research and application progress of these compounds in the anti-cancer field.
Key words:  anti-cancer drugs  anticancer activity  metal complexes